Strategic Asset Leasing, Inc. (LEAS) Stock
Anew Medical, Inc., located in Omaha, Nebraska, specializes in the creation of biological therapies. These medicines are designed to combat various health issues, including oncological, cardiac, and neurological conditions.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Strategic Asset Leasing, Inc.
Anew Medical, Inc., located in Omaha, Nebraska, specializes in the creation of biological therapies. These medicines are designed to combat various health issues, including oncological, cardiac, and neurological conditions.
Strategic Asset Leasing, Inc. (LEAS) stock trades at $0.00 with a market capitalization of $211458. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.50, reflecting a net loss over the last twelve months, price-to-book of 0.21, price-to-sales of 0.00.
On profitability, Strategic Asset Leasing, Inc. generates a return on equity (ROE) of -100.00% (negative, reflecting a net loss), return on capital employed of -48.71%.
Official website: klothoneuro.com
Related Industrials Stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.